ICECURE MEDICAL LTD (ICCM) Fundamental Analysis & Valuation

NASDAQ:ICCM • IL0011224156

Current stock price

0.665 USD
-0.06 (-8.9%)
At close:
0.6321 USD
-0.03 (-4.95%)
After Hours:

This ICCM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ICCM Profitability Analysis

1.1 Basic Checks

  • ICCM had negative earnings in the past year.
  • ICCM had a negative operating cash flow in the past year.
  • In the past 5 years ICCM always reported negative net income.
  • ICCM had a negative operating cash flow in each of the past 5 years.
ICCM Yearly Net Income VS EBIT VS OCF VS FCFICCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

  • With a Return On Assets value of -101.41%, ICCM is not doing good in the industry: 80.98% of the companies in the same industry are doing better.
  • ICCM has a Return On Equity of -164.30%. This is in the lower half of the industry: ICCM underperforms 71.74% of its industry peers.
Industry RankSector Rank
ROA -101.41%
ROE -164.3%
ROIC N/A
ROA(3y)-89.11%
ROA(5y)-66.89%
ROE(3y)-136.41%
ROE(5y)-102.39%
ROIC(3y)N/A
ROIC(5y)N/A
ICCM Yearly ROA, ROE, ROICICCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600 800 1K

1.3 Margins

  • With a Gross Margin value of 35.06%, ICCM is not doing good in the industry: 72.83% of the companies in the same industry are doing better.
  • ICCM's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for ICCM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.03%
GM growth 5Y4.86%
ICCM Yearly Profit, Operating, Gross MarginsICCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ICCM Health Analysis

2.1 Basic Checks

  • ICCM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ICCM has been increased compared to 1 year ago.
  • Compared to 5 years ago, ICCM has more shares outstanding
  • There is no outstanding debt for ICCM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ICCM Yearly Shares OutstandingICCM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ICCM Yearly Total Debt VS Total AssetsICCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • ICCM has an Altman-Z score of -8.10. This is a bad value and indicates that ICCM is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -8.10, ICCM is doing worse than 76.63% of the companies in the same industry.
  • ICCM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -8.1
ROIC/WACCN/A
WACC8.58%
ICCM Yearly LT Debt VS Equity VS FCFICCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • A Current Ratio of 2.38 indicates that ICCM has no problem at all paying its short term obligations.
  • ICCM has a Current ratio (2.38) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.90 indicates that ICCM should not have too much problems paying its short term obligations.
  • ICCM has a Quick ratio (1.90) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.38
Quick Ratio 1.9
ICCM Yearly Current Assets VS Current LiabilitesICCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. ICCM Growth Analysis

3.1 Past

  • ICCM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.77%, which is quite good.
  • The Revenue for ICCM has decreased by -18.96% in the past year. This is quite bad
  • ICCM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.37% yearly.
EPS 1Y (TTM)8.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)-18.96%
Revenue growth 3Y-7.36%
Revenue growth 5Y15.37%
Sales Q2Q%28.4%

3.2 Future

  • Based on estimates for the next years, ICCM will show a very strong growth in Earnings Per Share. The EPS will grow by 23.59% on average per year.
  • The Revenue is expected to grow by 90.27% on average over the next years. This is a very strong growth
EPS Next Y26.9%
EPS Next 2Y22.76%
EPS Next 3Y20.78%
EPS Next 5Y23.59%
Revenue Next Year11.03%
Revenue Next 2Y20.78%
Revenue Next 3Y104.63%
Revenue Next 5Y90.27%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ICCM Yearly Revenue VS EstimatesICCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50M 100M
ICCM Yearly EPS VS EstimatesICCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 0.2 -0.2 0.4 -0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. ICCM Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ICCM. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ICCM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ICCM Price Earnings VS Forward Price EarningsICCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ICCM Per share dataICCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2

4.3 Compensation for Growth

  • ICCM's earnings are expected to grow with 20.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.76%
EPS Next 3Y20.78%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ICCM Dividend Analysis

5.1 Amount

  • ICCM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ICCM Fundamentals: All Metrics, Ratios and Statistics

ICECURE MEDICAL LTD

NASDAQ:ICCM (3/17/2026, 8:23:02 PM)

After market: 0.6321 -0.03 (-4.95%)

0.665

-0.06 (-8.9%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-03
Earnings (Next)05-06
Inst Owners0.76%
Inst Owner Change78.23%
Ins Owners40.42%
Ins Owner ChangeN/A
Market Cap45.86M
Revenue(TTM)2.98M
Net Income(TTM)-15.29M
Analysts82.5
Price Target3.19 (379.7%)
Short Float %1.49%
Short Ratio2.46
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.07%
Min EPS beat(2)-17.65%
Max EPS beat(2)9.5%
EPS beat(4)2
Avg EPS beat(4)3.44%
Min EPS beat(4)-17.65%
Max EPS beat(4)26.47%
EPS beat(8)5
Avg EPS beat(8)4.51%
EPS beat(12)8
Avg EPS beat(12)5.2%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.8%
Min Revenue beat(2)-22.31%
Max Revenue beat(2)16.71%
Revenue beat(4)1
Avg Revenue beat(4)-7.62%
Min Revenue beat(4)-22.31%
Max Revenue beat(4)16.71%
Revenue beat(8)3
Avg Revenue beat(8)-5.39%
Revenue beat(12)3
Avg Revenue beat(12)-12.47%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)11.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 15.41
P/FCF N/A
P/OCF N/A
P/B 4.93
P/tB 4.93
EV/EBITDA N/A
EPS(TTM)-0.26
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS0.04
BVpS0.13
TBVpS0.13
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -101.41%
ROE -164.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.06%
FCFM N/A
ROA(3y)-89.11%
ROA(5y)-66.89%
ROE(3y)-136.41%
ROE(5y)-102.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.03%
GM growth 5Y4.86%
F-Score2
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 11.76%
Cap/Sales 1.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.38
Quick Ratio 1.9
Altman-Z -8.1
F-Score2
WACC8.58%
ROIC/WACCN/A
Cap/Depr(3y)175.33%
Cap/Depr(5y)260.07%
Cap/Sales(3y)15.28%
Cap/Sales(5y)12.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y26.9%
EPS Next 2Y22.76%
EPS Next 3Y20.78%
EPS Next 5Y23.59%
Revenue 1Y (TTM)-18.96%
Revenue growth 3Y-7.36%
Revenue growth 5Y15.37%
Sales Q2Q%28.4%
Revenue Next Year11.03%
Revenue Next 2Y20.78%
Revenue Next 3Y104.63%
Revenue Next 5Y90.27%
EBIT growth 1Y-5.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y4.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.83%
OCF growth 3YN/A
OCF growth 5YN/A

ICECURE MEDICAL LTD / ICCM Fundamental Analysis FAQ

What is the fundamental rating for ICCM stock?

ChartMill assigns a fundamental rating of 3 / 10 to ICCM.


What is the valuation status of ICECURE MEDICAL LTD (ICCM) stock?

ChartMill assigns a valuation rating of 1 / 10 to ICECURE MEDICAL LTD (ICCM). This can be considered as Overvalued.


How profitable is ICECURE MEDICAL LTD (ICCM) stock?

ICECURE MEDICAL LTD (ICCM) has a profitability rating of 1 / 10.


What is the financial health of ICECURE MEDICAL LTD (ICCM) stock?

The financial health rating of ICECURE MEDICAL LTD (ICCM) is 5 / 10.


What is the earnings growth outlook for ICECURE MEDICAL LTD?

The Earnings per Share (EPS) of ICECURE MEDICAL LTD (ICCM) is expected to grow by 26.9% in the next year.